Dilution is normal in a growth company, however continued discounted "toxic" equity dilution is almost always bad.
Also, TRTC's revenue growth is flat, thus can't command a growth stock multiple.
Always remember the insiders paid themselves first and actually own only a small percentage of the outstanding stock, the retail bagholders own the bulk of the shares and all the risk.